EurekAlert! In the Spotlight

Welcome to In the Spotlight, where each month we shine a light on something exciting, timely, or simply fascinating from the world of science.

This month, we're turning our attention to Breast Cancer Awareness Month, a time dedicated to increasing awareness, supporting early detection, and highlighting the ongoing research shaping the future of breast cancer treatment and prevention.

Latest News Releases

Updates every hour. Last Updated: 28-Oct-2025 04:11 ET (28-Oct-2025 08:11 GMT/UTC)

2-Jun-2025

Finnish researchers’ discovery may reveal why breast cancer is not always responsive to immunotherapy

University of Helsinki
Peer-Reviewed Publication

A Finnish discovery opens the door to more personalised cancer care. The research model is attracting global interest.

Journal: Nature Communications
Funder: Academy of Finland, Finnish Cancer Organization, Finnish Medical Foundation, Jane and Aatos Erkko Foundation, Biomedicum Helsinki Foundation, Eemil Aaltonen Foundation, Finnish Foundation for Technology Promotion, Business Finland, European Union’s Horizon 2020 Research and Innovation Programme

2-Jun-2025

Does a culturally tailored quality of life intervention benefit Latina breast cancer survivors and caregivers?

Wiley
Peer-Reviewed Publication

A recent randomized controlled trial published by Wiley online in CANCER assessed the benefits of a group-based intervention that fosters communication and coping skills in a culturally tailored way for Latina breast cancer survivors and their caregivers.

Journal: Cancer

1-Jun-2025

Switch to experimental drug after liquid biopsy detection of breast cancer recurrence improves outcomes

Weill Cornell Medicine
Peer-Reviewed Publication

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early detection of a treatment-resistance mutation, followed by a switch to a new type of treatment, substantially extends the period of tumor control compared to standard care.

Journal: New England Journal of Medicine

31-May-2025

ADC combination outperforms standard treatment of advanced triple-negative breast cancer

Dana-Farber Cancer Institute
Reports and Proceedings

Dana-Farber Cancer Institute presents potentially practice changing results from the phase 3 ASCENT-04/KEYNOTE-D19 clinical trial at American Society of Clinical Oncology (ASCO) annual meeting

Meeting: 2025 ASCO Annual Meeting

30-May-2025

ASCO 2025: Pancreatic cancer blood tests, genetic predictors of breast cancer survival and sarcoma treatment response prediction tools among Ohio State findings

Ohio State University Wexner Medical Center
Meeting Announcement

COLUMBUS, Ohio – Pancreatic cancer blood tests, genetic predictors of breast cancer survival and sarcoma treatment response prediction tools are among the research topics being presented by scientists from The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting being held from May 30-June 3 in Chicago.

Meeting: 2025 ASCO Annual Meeting

30-May-2025

Routine breast cancer screening brings better outcomes for patients

Radiological Society of North America
Peer-Reviewed Publication

Researchers have discovered that, compared to breast cancer that is symptom-detected, patients with breast cancer detected via routine screening mammography are more likely to have improved clinical outcomes, according to a new study.

Journal: Radiology Imaging Cancer

29-May-2025

ASCO 2025: Alcohol-fueled cancer deaths are on the rise in the US

University of Miami Miller School of Medicine
Reports and Proceedings

A new study led by experts at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, is the first to look at trends over time in alcohol-linked cancer mortality across the United States. The findings, titled “Escalating Impact of Alcohol-Related Cancer Mortality in the U.S.: A call for action,” will be presented May 31 at ASCO 2025.